Clin2
NCT06383689Worth exploringRecruiting

Improving comfort during epilepsy monitoring

Symptomatic Epilepsy

Part of Brain & nervous system clinical trials.

This study tests if changing how we give placebo pills during long hospital monitoring can make the experience better and less stressful for people with epilepsy. The goal is to improve care for those who need this test before epilepsy surgery.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
90 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are scheduled for long-term video-EEG monitoring as part of your epilepsy workup.
  • You are able to give your own consent to participate.
  • You do not need a legal guardian to make decisions for you.
  • You are 18 years or older (or the legal age in your country).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07507240Not yet recruiting
Monitoring and nurse support after epilepsy treatment change

This trial tests a care pathway that includes remote monitoring and support from a nurse after you start a new anti-epileptic medication. It aims to see if this approach helps you manage your treatment changes more safely and conveniently.

Toulouse, Non
NCT05594017Recruiting· Early Phase 1
Test medicine to change brain rhythms and study memory

This early research study tests whether a medicine can change the brain’s electrical “rhythms” while people do memory-related tasks. It may help researchers understand how brain timing affects memory in people who are already being evaluated with specialized brain electrode monitoring.

Dallas, Texas
NCT06612775Not yet recruiting· Phase 2
Testing CB03-154 for adults with focal epilepsy

This trial tests a new medication, CB03-154, to see if it is safe and can reduce seizures in adults with focal epilepsy. You may be able to join if you have had focal epilepsy for at least 2 years and are on a stable dose of 1 to 3 anti-seizure medications.

NCT05716100Recruiting· Phase 3
Study drug for focal epilepsy that isn’t controlled on current meds

This trial tests XEN1101 compared with a placebo (inactive pill) in people with focal-onset seizures that haven’t been fully controlled despite trying at least two anti-seizure medicines. If you qualify, you may help researchers see whether the study drug reduces seizure frequency and improves control.

Little Rock, Arkansas
NCT05845255Recruiting
Test wearable monitoring for epilepsy quality of life and safety

This study tests a wearable device that records seizure-related information to understand how epilepsy affects daily life and safety. It may help your care team better track seizures in real-world settings and understand quality-of-life changes.

Kork
NCT07721272Not yet recruiting· Early Phase 1
Brain During Surgery: Thinking and Medication Study

This study tests whether giving a drug that affects brain chemistry during brain surgery can improve thinking and attention for people with essential tremor or epilepsy. If you qualify, you might receive the drug or a placebo during your electrode placement surgery to see how it affects your cognition.

Dallas, Texas

Hear when a new Symptomatic Epilepsy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.